Invest in ME Conference 12: First Class in Every Way
OverTheHills wraps up our series of articles on this year's 12th Invest in ME International Conference (IIMEC12) in London with some reflections on her experience as a patient attending the conference for the first time.
Discuss the article on the Forums.

Human Herpesvirus 6 downregulates the expression of activating ligands during lytic infection to esc

Discussion in 'Other Health News and Research' started by JaimeS, Aug 23, 2016.

  1. JaimeS

    JaimeS Senior Member

    Mid-Ohio Valley, United States
    Full title:
    Human Herpesvirus 6 downregulates the expression of activating ligands during lytic infection to escape elimination by natural killer cells

    + Author Affiliations

    The Lautenberg Center for General and Tumor Immunology, The BioMedical Research Institute Israel

    Canada of the Faculty of Medicine, The Hebrew University Hadassah Medical School, Jerusalem, Israel.

    Department of Pharmacology and Experimental Therapeutics, School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel.

    Central Virology Laboratory, The Chaim Sheba Medical Center, Ramat-Gan, Israel.


    The herpesviridae family consists of eight viruses, most of which infect a majority in the human population. One of the less-studied members is Human Herpesvirus 6 (HHV-6, Roseolovirus) that causes a mild, well-characterized childhood disease. Primary HHV-6 infection is followed by life-long latency. Reactivation frequently occurs in immune-compromised patients, such as those suffering from HIV infection, cancer or following transplantation, and causes potentially life-threatening complications. In this study, we investigated the mechanisms HHV-6 utilizes to remain undetected by natural killer (NK) cells, key participants in the innate immune response to infections. We revealed viral mechanisms which downregulate ligands for two powerful activating NK cell receptors: ULBP1, ULBP3 and MICB that trigger NKG2D, and B7-H6 that activates NKp30. Accordingly, this downregulation impaired NK cells' ability to recognize HHV-6 infected cells. Thus, we describe for the first time immune evasion mechanisms of HHV-6 that protect lytically infected cells from NK elimination.


    Human Herpesvirus 6 (HHV-6) latently infects a large portion of the human population and can reactivate in humans lacking a functional immune system, like cancer or AIDS patients. Under these conditions, it can cause life-threatening diseases. To date, actions and interplay of immune cells, and particularly cells of the innate immune system, during HHV-6 infection are poorly defined. Therefore, we aimed to understand how cells undergoing lytic HHV-6 infection are interacting with natural killer (NK) cells, an innate lymphocyte constituting the first line of defense against viral intruders. We show that HHV-6 suppresses the expression of surface proteins that alert the immune cells by triggering two major receptors on natural killer (NK) cells, NKG2D and NKp30. In consequence, HHV-6 can replicate undetected by innate immune system and potentially spread infection throughout the body.

    This study advances the understanding of HHV-6 biology and its measures used to successfully escape immune elimination.


    Correspondence should be sent to Ofer Mandelboim,, Phone: +972-2-675-7515, Fax: +972-2-643-0834

    osisposis, Paralee and Valentijn like this.
  2. Paralee

    Paralee Senior Member

    I actually understood some of that. Now to find out if there's a test for it. I don't really list everything I've had anymore, I'm always leaving something out, but I've had cancer twice.

    Thanks @JaimeS , another rabbit hole to wander through.
  3. JaimeS

    JaimeS Senior Member

    Mid-Ohio Valley, United States
    You're very welcome, Paralee! There are tests out there for the HHVs; I know Redlabs does one.
    Paralee likes this.

See more popular forum discussions.

Share This Page